The Effect of vaginal Bromocriptine in controlling Adenomyosis symptoms
Nahed ezzat allam
68 participants
Feb 5, 2019
Interventional
Conditions
Summary
Hysterectomy (removal of womb and ovaries)considered the most common treatment for symptomatic adenomyosis. However due to its association with perioperative , postoperative morbidity, decreased quality of life and high healthcare costs,it looks wise to find another non surgical treatment. Hysterectomy is also not appropriate for women who wish to preserve their fertility and availability of a noninvasive approach for the treatment of adenomyosis may be preferable for most women and could reduce the burden on healthcare systems by a major reduction in surgical intervention. Untill now no proved evidence for any mode of treatment. this study tried to find appropriate medical treatment for this problem.
Eligibility
Inclusion Criteria1
- women complaining of symptoms related to presence of adenomyosis like dysmenorrhea, menstrual irregularities and or subfertility.
Exclusion Criteria5
- -Patients on hormonal or intrauterine device as contraception
- -Active pelvic infection
- - Pregnant or breast fed women
- -Hypersenstivity or contraindication to bromocriptine,
- -local contraception users
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
vaginal bromocriptine suppository 0.5 mg twice daily inserted by patient for six months, the patient will be phoned monthly to monitor adherence to the intervention
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12617001122347